Cart
sales@molnova.com
Type A Allatostatin I
CAS No. 123209-95-0
Type A Allatostatin I( —— )
Catalog No. M30357 CAS No. 123209-95-0
Type A Allatostatin I is a tridecapeptide. Allatostatins are pleiotropic neuropeptides for inhibition of juvenile hormone synthesis in insects.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
Biological Information
-
Product NameType A Allatostatin I
-
NoteResearch use only, not for human use.
-
Brief DescriptionType A Allatostatin I is a tridecapeptide. Allatostatins are pleiotropic neuropeptides for inhibition of juvenile hormone synthesis in insects.
-
DescriptionType A Allatostatin I is a tridecapeptide. Allatostatins are pleiotropic neuropeptides for inhibition of juvenile hormone synthesis in insects.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number123209-95-0
-
Formula Weight1335.51
-
Molecular FormulaC61H94N18O16
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical NameSequence:{Ala}{Pro}{Ser}{Gly}{Ala}{Gln}{Arg}{Leu}{Tyr}{Gly}{Phe}{Gly}{Leu}-NH2
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
Stay B, et al. Allatostatin-immunoreactive neurons projecting to the corpora allata of adult Diploptera punctata. Cell Tissue Res. 1992 Oct;270(1):15-23.
molnova catalog
related products
-
Lupartumab
Lupartumab (BAY 1112623) is a monoclonal antibody targeting LYPD3 (C4.4A) and is employed in the synthesis of antibody-active molecular couplers for studying LYPD3-associated tumor diseases.
-
3beta-Hydroxylanosta...
3beta-Hydroxylanosta-8,24-diene-21-al may have cancer cell growth inhibitory activity against P388, HL-60, L1210 and KB cell lines.
-
116-9e
116-9e (MAL2-11B) is a potent Hsp70 co-chaperone DNAJA1 inhibitor with antiviral properties, inhibiting simian virus 40 (SV40) replication, tumour antigen (TAg) endogenous ATPase activity, and TAg-mediated activation of Hsp70. 116-9e can be used to study cancer drug resistance.
